6Genest JJr,McNamara JR,Ordoras JM, et al, Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery disease, Am J Cardiol, 1991,67 : 1039-1045.
7Lipid Research Clinics Coronary Prevention Trial: I. Reduction in incidence of coronary heart disease. JAMA,1984,251:351-364.
8Soma MR,Osnago-Gadda I,Paoletti R,et al . The lowing of lipoprotein (a) induced by estrogen plus progesterone replacement therapy in postmenopausal women. Arch Intern Med, 1993,153: 1462-1468.
9Swislocki A. Insulin resistance and hypertension. Am J Med Sci, 1990,300 : 104-115.
10Wolfe BM,Huff MW, Effects of continuous low-dosage hormonal replacement therapy on lipopretein metabolism in postmenopausal women. Metabolism, 1995, 40: 410-417.
5The ESHRE Capri Workshop Group.Hormones and cardiovascular health in women[J].Hum Reprod Update,2006,5(12):483-497.
6BEALE C M,COLLINS P.The menopause and the cardiovascular system[J].Bailliere Clin Obstet Gynaecol,1996,10(3):483-513.
7JACOBSEN B K,NILSSEN S,HEUDQ I,et al.Does age at natural menopause affect mortality from ischemic heart disease?[J].J Clin Epidemiol,1997,50(4):475-479.
8SHLIPAK M G,SIMON J A,VITTINGHOFF E,et al.Estrogen and progestin,lipoprotein(a),and the risk of recurrent coronary heart disease events after menopause[J].JAMA,2000,283(14):1845-1852.
9TR(E)MOLLI(E)RES F A,POUILLES J M,CAUNEILLE C,et al.Coronary heart disease risk factors and menopause:a study in 1684 French women[J].Atherosclerosis,1999,142(2):415-423.
10GaoRL.Guideline for diagnosis and treatment of acute myocardial infarction .中国循环杂志,2001,16:407-422.
